Study population
head and neck cancers, gynaecological cancer, lung cancer, Arkenau, lymphoma
LUNG CANCER, OTHER CANCER, HEPATOCELLULAR CARCINOMA, HEAD AND NECK CANCER, LYMPHOMA
There were 414 patients (157 [38%] male and 257 [62%] female) recruited in 40 Phase I studies at NCIS (Table Baseline and treatment characteristics.Note: 1. The figures are presented in terms of frequency and percentage, unless otherwise stated.2. Arkenau et al. [3. In total, 12 patients in the NCIS study population did not have ECOG PS recorded.4. Median albumin was 36 (IQR 33–39) in Kumar et al. [5. LDL was presented based on the institutional upper limit of normal i.e., 580 IU/L for NCIS study population and 192 U/L for Arkenau et al. [6. For Arkenau et al. [7. For Arkenau et al. [8. Other cancers for the NCIS population included lymphoma (3.4%), hepatocellular carcinoma (6.3%), head and neck cancers (8.0%), lung cancer (8.2%) and gynaecological cancer (12.8%).